X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2303) 2303
Publication (430) 430
Book Chapter (34) 34
Book Review (24) 24
Newsletter (12) 12
Conference Proceeding (5) 5
Government Document (5) 5
Magazine Article (4) 4
Web Resource (3) 3
Newspaper Article (2) 2
Reference (2) 2
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1099) 1099
animals (804) 804
index medicus (751) 751
shigella (665) 665
microbiology (608) 608
immunology (569) 569
infectious diseases (440) 440
mice (395) 395
female (383) 383
bacteria (348) 348
virulence (340) 340
escherichia-coli (333) 333
shigella flexneri - immunology (319) 319
dysentery, bacillary - prevention & control (318) 318
male (310) 310
vaccines (292) 292
dysentery, bacillary - microbiology (286) 286
shigellosis (285) 285
shigella flexneri (273) 273
shigella-flexneri (270) 270
diarrhea (267) 267
infections (252) 252
research article (245) 245
dysentery, bacillary - immunology (234) 234
research (227) 227
dysentery, bacillary - epidemiology (210) 210
child, preschool (206) 206
shigella flexneri - genetics (205) 205
molecular sequence data (203) 203
bacterial vaccines - immunology (200) 200
biochemistry & molecular biology (198) 198
immunization (195) 195
child (194) 194
proteins (194) 194
adult (192) 192
vaccine (191) 191
salmonella (190) 190
antigens (189) 189
vaccination (188) 188
shigella sonnei - immunology (180) 180
bacterial proteins - genetics (178) 178
infant (176) 176
children (170) 170
dysentery (169) 169
epidemiology (162) 162
infection (162) 162
immunogenicity (161) 161
pathogens (161) 161
analysis (160) 160
health aspects (155) 155
medicine, research & experimental (155) 155
shigella flexneri - pathogenicity (151) 151
adolescent (150) 150
shigella - immunology (149) 149
escherichia coli (148) 148
plasmids (145) 145
mice, inbred balb c (140) 140
flexneri (139) 139
mutation (138) 138
administration, oral (136) 136
bacterial proteins - metabolism (136) 136
guinea pigs (136) 136
genes (135) 135
bacterial vaccines - administration & dosage (131) 131
e coli (130) 130
lipopolysaccharide (130) 130
antigens, bacterial - immunology (129) 129
identification (125) 125
medicine (124) 124
shigella sonnei (124) 124
feces - microbiology (122) 122
antibodies (121) 121
shigella - isolation & purification (120) 120
antibiotics (119) 119
shigella vaccines - immunology (117) 117
bacillary dysentery (115) 115
diarrhea - microbiology (114) 114
escherichia coli - genetics (113) 113
bacterial vaccines (112) 112
epithelial-cells (112) 112
rabbits (112) 112
antibodies, bacterial - blood (111) 111
multidisciplinary sciences (111) 111
pathogenesis (111) 111
shigella - genetics (111) 111
public, environmental & occupational health (110) 110
salmonella-typhimurium (109) 109
genetic aspects (105) 105
immunity (105) 105
physiological aspects (102) 102
shigella - pathogenicity (102) 102
antimicrobial resistance (99) 99
flexneri 2a (99) 99
lipopolysaccharides - immunology (99) 99
shigella dysenteriae - immunology (96) 96
life sciences (94) 94
public health (94) 94
strains (94) 94
anti-bacterial agents - pharmacology (93) 93
prevalence (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2154) 2154
Russian (117) 117
French (21) 21
German (20) 20
Chinese (16) 16
Persian (8) 8
Polish (4) 4
Japanese (3) 3
Korean (3) 3
Spanish (3) 3
Ukrainian (3) 3
Czech (2) 2
Bulgarian (1) 1
Italian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infectious Diseases, ISSN 0022-1899, 01/2017, Volume 215, Issue 2, pp. 259 - 268
Journal Article
Infection and Immunity, ISSN 0019-9567, 03/2012, Volume 80, Issue 3, pp. 1222 - 1231
Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
FLEXNERI 2A | IMMUNE-RESPONSE | INFECTIOUS DISEASES | HEALTHY-ADULTS | IMMUNOGENICITY | CONJUGATE VACCINES | SAFETY | VOLUNTEERS | LIPOPOLYSACCHARIDE | SHIGA TOXIN | SERUM ANTIBODIES | IMMUNOLOGY | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Shigella flexneri - pathogenicity | Antigens, Bacterial - immunology | Vaccines, Synthetic - immunology | Antigens, Bacterial - genetics | Dysentery, Bacillary - prevention & control | Shigella flexneri - immunology | Escherichia coli Proteins - administration & dosage | Membrane Transport Proteins - genetics | Female | Bacterial Proteins - immunology | Dysentery, Bacillary - immunology | Shigella Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Bacterial Proteins - genetics | Antigens, Bacterial - administration & dosage | Vaccines, Subunit - immunology | Bacterial Proteins - administration & dosage | Enterotoxins - administration & dosage | Animals | Shigella sonnei - pathogenicity | Shigella Vaccines - immunology | Vaccines, Subunit - administration & dosage | Shigella Vaccines - genetics | Bacterial Toxins - administration & dosage | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | Membrane Transport Proteins - immunology | Membrane Transport Proteins - administration & dosage | Shigella sonnei - immunology | Microbial Immunity and Vaccines
Journal Article
Accounts of Chemical Research, ISSN 0001-4842, 05/2017, Volume 50, Issue 5, pp. 1270 - 1279
Since 2004, when the first synthetic glycoconjugate vaccine against the pneumonia and meningitis causing bacterium Haemophilus influenza type b (Hib) approved... 
CAPSULAR POLYSACCHARIDE | REPEATING UNIT | INFLUENZAE TYPE-B | PILUS PROTEIN | SHIGELLA-DYSENTERIAE TYPE-1 | TYROSINE-DIRECTED CONJUGATION | ESCHERICHIA-COLI | BIOLOGICAL EVALUATION | NEISSERIA-MENINGITIDIS SEROGROUP | FREE CLICK CHEMISTRY | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
Journal Article
Antiviral Research, ISSN 0166-3542, 02/2014, Volume 102, pp. 61 - 69
Despite the success of L1 virus-like particles (VLPs) vaccines in prevention of high-risk human papillomavirus (HPV) infection and cervical cancer,... 
Genomic integration | Shigella sonnei | Human papillomavirus vaccine | Autotransporter | CONTROLLED-TRIAL | NEUTRALIZING ANTIBODIES | HUMAN-PAPILLOMAVIRUS TYPE-16 | INSECT CELLS | MAJOR CAPSID PROTEIN | CERVICAL-CANCER | IN-VITRO | VIROLOGY | EPITHELIAL-CELLS | VIRUS-LIKE PARTICLES | PHARMACOLOGY & PHARMACY | ENTEROTOXIGENIC ESCHERICHIA-COLI | Recombinant Fusion Proteins - immunology | Papillomavirus Vaccines - genetics | Vaccines, Synthetic - immunology | Shigella sonnei - genetics | Antibodies, Viral - blood | Antibodies, Bacterial - analysis | Drug Carriers | Vaccination - methods | Antibodies, Viral - analysis | Leukocytes, Mononuclear - immunology | Vaccines, Attenuated - administration & dosage | Capsid Proteins - immunology | Oncogene Proteins, Viral - genetics | Bacterial Proteins - immunology | Antibodies, Bacterial - blood | Papillomavirus Vaccines - administration & dosage | Cell Surface Display Techniques - methods | Guinea Pigs | Shigella Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Bacterial Proteins - genetics | Vaccines, Attenuated - immunology | Animals | Shigella Vaccines - immunology | Shigella Vaccines - genetics | Recombinant Fusion Proteins - genetics | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Vaccines, Synthetic - administration & dosage | Genetic Vectors | Shigella sonnei - immunology | Capsid Proteins - genetics | Vaccines, Attenuated - genetics | Papillomavirus infections | Vaccines
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2006, Volume 24, Issue 18, pp. 3856 - 3864
Live bacterial vaccines represent a highly valid preventive strategy in the fight against infectious disease. However, the road from research to market is... 
Environmental risk assessment | Live attenuated vaccine | Biosafety | GMO-based vaccines | MEDICINE, RESEARCH & EXPERIMENTAL | SAFETY | SALMONELLA-TYPHI | CANDIDATE | TY 21A | IMMUNOLOGY | environmental risk assessment | VIBRIO-CHOLERAE | live attenuated vaccine | IMMUNOGENICITY | CVD 103-HGR | BIOLOGICAL CONTAINMENT | VETERINARY SCIENCES | ATTENUATED SALMONELLA | STRAIN | biosafety | Cholera Vaccines - adverse effects | Cholera Vaccines - immunology | Shigella flexneri - genetics | Bacterial Vaccines - genetics | Humans | Cholera Vaccines - genetics | Drug Approval | Vaccines, Synthetic - immunology | Shigella Vaccines - adverse effects | Typhoid-Paratyphoid Vaccines - adverse effects | Shigella flexneri - immunology | Vaccines, Synthetic - adverse effects | Drug-Related Side Effects and Adverse Reactions | Organisms, Genetically Modified | Drug and Narcotic Control | Risk Assessment | Typhoid-Paratyphoid Vaccines - genetics | Europe | Vaccines, Synthetic - genetics | Bacterial Vaccines - adverse effects | Vaccines, Attenuated - immunology | Bacterial Vaccines - immunology | Shigella Vaccines - immunology | Shigella Vaccines - genetics | Vaccines, Attenuated - adverse effects | Typhoid-Paratyphoid Vaccines - immunology | Vaccines, Attenuated - genetics | Laws, regulations and rules | Analysis | Vaccines | Antibiotics | Advantages | Genes | Principles | Regulation | Organisms | Mutation | Licensing
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 34, pp. 5159 - 5171
Highlights ► New, second-generation live attenuated Shigella flexneri 2a vaccine candidates. ► WRSf2G12 and WRSf2G15 are as invasive as parental strain 2457T... 
Allergy and Immunology | S. flexneri 2a vaccine | Live Shigella vaccine | WRSf2G12 and WRSf2G15 | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | SUICIDE VECTOR | LARGE VIRULENCE PLASMID | GUINEA-PIG | IMMUNOLOGY | PIG KERATOCONJUNCTIVITIS MODEL | PROTECTIVE EFFICACY | INTESTINAL EPITHELIUM | DIVERSE SEROTYPES | ENTEROPATHOGENIC ESCHERICHIA-COLI | MONOCLONAL-ANTIBODIES | Shigella flexneri - genetics | Humans | Shigella flexneri - pathogenicity | Immunity, Mucosal | Vaccines, Synthetic - immunology | Shigella flexneri - immunology | Dysentery, Bacillary - therapy | Gene Deletion | Vaccines, Attenuated - administration & dosage | Immunization Schedule | Bacterial Proteins - immunology | Macrophages - immunology | Macrophages - microbiology | Disease Models, Animal | Dysentery, Bacillary - microbiology | Dysentery, Bacillary - immunology | Genes, Bacterial | Guinea Pigs | Drug Stability | Shigella Vaccines - administration & dosage | Vaccines, Synthetic - genetics | Bacterial Proteins - genetics | Vaccines, Attenuated - immunology | Animals | Shigella Vaccines - immunology | Shigella Vaccines - genetics | Antibodies, Bacterial - immunology | Bacterial Proteins - metabolism | Mice | HeLa Cells | Vaccines, Synthetic - administration & dosage | Vaccines, Attenuated - genetics | Genetic research | Bacterial infections | Vaccines | Genes
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 37, pp. 6371 - 6378
Journal Article